[ad_1]
New York, April 27, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Posterior Segment Eye Disorders Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” – https://www.reportlinker.com/p06221879/?utm_source=GNW
The COVID-19 pandemic led to disruption in not only the research and development activities of other therapies and drugs for medical conditions other than COVID-19 but also impacted the treatment procedures and supply chain of the pharmaceuticals and medical devices around the world which also impacted the studied market of posterior segment eye disorders.
For instance, according to a health article published in March 2021, titled “The Covid-19 pandemic accelerates the worsening of glaucoma cases”, the impact of the COVID-19 has caused very serious and irreversible consequences in people with glaucoma, who have suffered Therefore a very rapid evolution of the disease and have not been able to carry out the follow-up by the specialist, which, in some cases, has resulted in a loss of the visual field. Therefore, the overall impact of the COVID-19 on the posterior segment eye disorders market was negative primarily due to the decline in the diagnostics and treatment procedures of the diseases associated with the posterior segment of the eye but with the ongoing vaccination programs and launch of new drugs against the COVID-19, the studied market is expected to beam back to its full potential in due time.
The posterior segment eye disorders are one of the major causes of the visual impairments around the world and their prevalence is growing gradually owing to the increase in the prevalence of eye diseases, diabetes, geriatric population, and other factors and with the increase in the burden of these diseases, the demand of diagnostics and treatment is increasing around the world which is driving the growth of the studied market of the posterior segment eye disorders.
For instance, according to the research study published in September 2020, titled “Cutting-edge advances in therapy for the posterior segment of the eye: Solid lipid nanoparticles and nanostructured lipid carriers”, posterior segment eye diseases can result in severe vision loss, and it affects more than 300 million people around the world, which shows a significant burden of the disorders around the world.
Also, there are several other research studies which showed that posterior eye disorders are associated with the loss of vision which is why the demand of diagnostics and therapeutics is increasing in the studied area of market and over the years, with the rising awareness about these diseases , the market of posterior segment eye disorders is expected to grow during the forecast period of the study.
Furthermore, the launch of new…
Full story available on Benzinga.com
[ad_2]
Source link
